liver and semaglutide The effect of on enzymes in subjects with obesity elevated alanine aminotransferase: data from a randomized phase 2 trial Semaglutide alleviates metabolic-linked liver disease

however, if you miss several doses, or dont make up your missed dose for an extended period of time, you may notice nausea, GI symptoms, increased appetite, blood sugar fluctuations, and weight gain

The term describes the visible facial aging that can accompany rapid, significant weight loss, characterized by: Hollowed, sunken cheeks where fullness once existed Prominent nasolabial folds (lines from nose to mouth corners) that deepen dramatically Jowl formation or worsening along the jawline Under-eye hollows and dark circles that create a tired appearance Temple hollowing that creates a gaunt, skeletal look Marionette lines extending from mouth corners downward Loose, sagging skin especially around the neck and lower face Increased wrinkles and crepiness from loss of skin elasticity According to a 2025 systematic review published in Plastic and Reconstructive Surgery , Ozempic face describes exaggerated volume loss from semaglutide therapy, resulting in advanced facial aging that has led to a measurable increase in facial restoration procedures Daneshgaran et al., 2025

M., Li, Y., Sun, C., Kinnunen, T

Because of this dual action, the reduction in food noise seen with GLP-1 therapy reflects both metabolic and behavioral effects

The monoclonal has already undergone a Phase 1 safety trial